Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATPase plasma membrane Ca2+ transporting 1 | 0.666 | 0.500 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 13 | 11 | 2009 | 2018 | ||||||||
|
ataxin 2 | 0.482 | 0.808 | 0.85 |
|
phenotype | 0.100 | None | 1.000 | 12 | 4 | 2009 | 2019 | ||||||||
|
unc-51 like kinase 4 | 0.722 | 0.385 | 4.4E-38 |
|
phenotype | 0.100 | None | 1.000 | 11 | 13 | 2009 | 2019 | ||||||||
|
SH2B adaptor protein 3 | 0.527 | 0.692 | 1.0E-04 |
|
phenotype | 0.100 | None | 1.000 | 11 | 2 | 2009 | 2019 | ||||||||
|
castor zinc finger 1 | 0.553 | 0.731 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 10 | 4 | 2011 | 2018 | ||||||||
|
SRY-box transcription factor 6 | 0.578 | 0.615 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 8 | 8 | 2013 | 2019 | ||||||||
|
Rho GTPase activating protein 42 | 0.792 | 0.385 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 8 | 6 | 2011 | 2018 | ||||||||
|
solute carrier family 39 member 8 | 0.584 | 0.769 | 0.67 |
|
phenotype | 0.100 | None | 1.000 | 8 | 2 | 2011 | 2019 | ||||||||
|
MDS1 and EVI1 complex locus | 0.513 | 0.731 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 7 | 6 | 2009 | 2018 | ||||||||
|
pleckstrin homology and RhoGEF domain containing G1 | 0.890 | 0.115 | 1.3E-02 |
|
phenotype | 0.100 | None | 1.000 | 7 | 5 | 2013 | 2018 | ||||||||
|
long intergenic non-protein coding RNA 2398 | 0.931 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 7 | 6 | 2015 | 2018 | |||||||||
|
leucine rich repeat containing 10B | 4.5E-02 |
|
phenotype | 0.100 | None | 1.000 | 6 | 3 | 2016 | 2018 | ||||||||||
|
potassium two pore domain channel subfamily K member 3 | 0.584 | 0.654 | 0.90 |
|
phenotype | 0.100 | None | 1.000 | 6 | 6 | 2016 | 2019 | ||||||||
|
C-terminal Src kinase | 0.606 | 0.692 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 6 | 2 | 2009 | 2018 | ||||||||
|
homeostatic iron regulator | 0.436 | 0.846 | 2.6E-08 |
|
phenotype | 0.100 | None | 1.000 | 6 | 2 | 2011 | 2018 | ||||||||
|
zinc finger protein 831 | 0.792 | 0.192 | 7.9E-10 |
|
phenotype | 0.100 | None | 1.000 | 6 | 5 | 2011 | 2018 | ||||||||
|
FES proto-oncogene, tyrosine kinase | 0.593 | 0.769 | 3.8E-15 |
|
phenotype | 0.100 | None | 1.000 | 6 | 2 | 2011 | 2018 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
phenotype | 0.100 | None | 1.000 | 6 | 2 | 2016 | 2019 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
phenotype | 0.100 | None | 1.000 | 6 | 5 | 2016 | 2018 | ||||||||
|
guanylate cyclase 1 soluble subunit alpha 1 | 0.686 | 0.577 | 3.1E-08 |
|
phenotype | 0.100 | None | 1.000 | 6 | 4 | 2011 | 2018 | ||||||||
|
calcium voltage-gated channel auxiliary subunit beta 2 | 0.659 | 0.538 | 2.7E-06 |
|
phenotype | 0.100 | None | 1.000 | 6 | 5 | 2009 | 2018 | ||||||||
|
calcium voltage-gated channel subunit alpha1 D | 0.582 | 0.577 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 5 | 6 | 2015 | 2019 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
phenotype | 0.100 | None | 1.000 | 5 | 2 | 2016 | 2018 | ||||||||
|
Mov10 RISC complex RNA helicase | 0.760 | 0.308 | 0.81 |
|
phenotype | 0.100 | None | 1.000 | 5 | 3 | 2011 | 2018 | ||||||||
|
ciliary associated calcium binding coiled-coil 1 | 1.000 | 0.038 | 3.7E-04 |
|
phenotype | 0.100 | None | 1.000 | 5 | 4 | 2009 | 2018 |